Cencora, Inc.

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Cencora, Inc. and other ETFs, options, and stocks.

About COR

Cencora, Inc. is a pharmaceutical sourcing and distribution services company. It operates through the United States (U.S.) Healthcare Solutions and International Healthcare Solutions segments. 

CEO
Robert P. Mauch
CEORobert P. Mauch
Employees
51,000
Employees51,000
Headquarters
Conshohocken, Pennsylvania
HeadquartersConshohocken, Pennsylvania
Founded
1947
Founded1947
Employees
51,000
Employees51,000

COR Key Statistics

Market cap
52.14B
Market cap52.14B
Price-Earnings ratio
20.48
Price-Earnings ratio20.48
Dividend yield
0.86%
Dividend yield0.86%
Average volume
2.08M
Average volume2.08M
High today
$269.47
High today$269.47
Low today
$264.61
Low today$264.61
Open price
$267.39
Open price$267.39
Volume
869.21K
Volume869.21K
52 Week high
$377.54
52 Week high$377.54
52 Week low
$244.82
52 Week low$244.82

Stock Snapshot

As of today, Cencora, Inc.(COR) shares are valued at $267.98. The company's market cap stands at 52.14B, with a P/E ratio of 20.48 and a dividend yield of 86.1%.

As of 2026-05-28, Cencora, Inc.(COR) stock has fluctuated between $264.61 and $269.47. The current price stands at $267.98, placing the stock +1.3% above today's low and -0.6% off the high.

Cencora, Inc.(COR) shares are trading with a volume of 869.21K, against a daily average of 2.08M.

In the last year, Cencora, Inc.(COR) shares hit a 52-week high of $377.54 and a 52-week low of $244.82.

In the last year, Cencora, Inc.(COR) shares hit a 52-week high of $377.54 and a 52-week low of $244.82.

COR News

MarketWatch 23h
Cencora Inc. stock underperforms Wednesday when compared to competitors - MarketWatch

...

Cencora Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Simply Wall St 23h
Is Cencora Starting To Look Attractive After Recent Healthcare Distribution Headlines?

If you are wondering whether Cencora at about US$270.78 is starting to look attractive or stretched, the key question is what you are really paying for its futu...

Is Cencora Starting To Look Attractive After Recent Healthcare Distribution Headlines?
TipRanks 1d
Cencora appoints Eva Boratto as CFO

Cencora (COR) appointed Eva Boratto EVP and CFO, effective June 29. Boratto succeeds James Cleary, who will be retiring from his role as EVP and CFO as previous...

Analyst ratings

78%

of 18 ratings
Buy
77.8%
Hold
22.2%
Sell
0%

More COR News

Nasdaq 6d
Cencora Raises FY26 Outlook; Plans Up To $2 Bln Addl. Share Repurchase

(RTTNews) - Cencora Inc. (COR), a pharmaceutical company, announced that it has raised the lower end of its fiscal 2026 adjusted earnings outlook. Further, the...

Cencora Raises FY26 Outlook; Plans Up To $2 Bln Addl. Share Repurchase

People also own

Based on the portfolios of people who own COR. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.